USS Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65,761
Closed -$3.26M 584
2022
Q4
$3.26M Hold
65,761
0.05% 428
2022
Q3
$2.14M Buy
65,761
+23,232
+55% +$958K 0.03% 480
2022
Q2
$1.68M Sell
42,529
-8,946
-17% -$478K 0.02% 560
2022
Q1
$3.6M Buy
51,475
+7,531
+17% +$550K 0.03% 508
2021
Q4
$3.42M Hold
43,944
0.03% 535
2021
Q3
$4.2M Buy
43,944
+2,921
+7% +$308K 0.04% 473
2021
Q2
$5.1M Hold
41,023
0.04% 255
2021
Q1
$5.41M Buy
41,023
+25,311
+161% +$3.46M 0.05% 233
2020
Q4
$2.08M Hold
15,712
0.02% 376
2020
Q3
$1.6M Buy
15,712
+819
+5% +$70.7K 0.02% 407
2020
Q2
$1.29M Buy
+14,893
New +$1.19M 0.01% 434

Other funds holding EXAS

USS Investment Management's EXAS Position: Q1 2023 in Review

USS Investment Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 65,761 shares — an estimated $3.26M sold.

USS Investment Management first reported a position in EXAS in Q2 2020 and held it in 11 quarters. The position peaked at $5.41M in Q1 2021. 584 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • USS Investment Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • USS Investment Management sold 65,761 Exact Sciences shares in Q1 2023, an estimated $3.26M.
  • USS Investment Management first reported a position in Exact Sciences in Q2 2020 and held it in 11 quarters.
  • USS Investment Management's Exact Sciences position peaked at $5.41M in Q1 2021.
  • 584 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on USS Investment Management's 13F filing for Q1 2023, filed 15 May 2023.